Zobrazeno 1 - 10
of 33
pro vyhledávání: '"I. A. Jacobson"'
Autor:
N H, Afdhal, S, Zeuzem, R T, Schooley, D L, Thomas, J W, Ward, A H, Litwin, H, Razavi, L, Castera, T, Poynard, A, Muir, S H, Mehta, L, Dee, C, Graham, D R, Church, A H, Talal, M S, Sulkowski, I M, Jacobson, Stefan, Zeuzem
Publikováno v:
Journal of Viral Hepatitis
SUMMARY. Emerging data indicate that all-oral antiviral treatments for chronic hepatitis C virus (HCV) will become a reality in the near future. In replacing interferon-based therapies, all-oral regimens are expected to be more tolerable, more effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f32dbf8c55ba220471a7f0771ca060cb
https://doi.org/10.1111/jvh.12173
https://doi.org/10.1111/jvh.12173
Autor:
I M, Jacobson, J-M, Pawlotsky, N H, Afdhal, G M, Dusheiko, X, Forns, D M, Jensen, F, Poordad, J, Schulz
Publikováno v:
Journal of viral hepatitis. 19
The aim of this study is to review clinical trial data on the newly approved protease inhibitors boceprevir and telaprevir to develop consensus recommendations on the optimal use of these agents for the treatment of patients with chronic hepatitis C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::251405c663fdae64f8176c0d581ee973
https://pubmed.ncbi.nlm.nih.gov/22404758
https://pubmed.ncbi.nlm.nih.gov/22404758
Publikováno v:
Journal of viral hepatitis. 19(4)
The treatment paradigm for hepatitis C virus (HCV) infection is at a critical point in its evolution. The addition of a protease inhibitor to peginterferon plus ribavirin has become the new standard-of-care treatment for most patients. Data from clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f15bf01e1a3d23ec833117bacae6f07a
https://pubmed.ncbi.nlm.nih.gov/22404721
https://pubmed.ncbi.nlm.nih.gov/22404721
Publikováno v:
Internal Medicine Journal. 41:437-438
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::007e3f01d1b08ef434f5319d70eff4a3
https://doi.org/10.1111/j.1445-5994.2011.02480.x
https://doi.org/10.1111/j.1445-5994.2011.02480.x
Publikováno v:
The American journal of gastroenterology. 91(5)
A case of "wandering spleen" associated with recurrent pancreatitis and diagnosed with computed tomography (CT), is reported. The entity was also associated with a rotated, distended stomach, gastric outlet obstruction secondary to extrinsic compress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4ac934cf63884b5971018b5f647fb1c0
https://pubmed.ncbi.nlm.nih.gov/8633547
https://pubmed.ncbi.nlm.nih.gov/8633547
Autor:
I S, Jacobson
Publikováno v:
Medical economics. 71(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::85928abe36a76d7c64dfbd02fe62419a
https://pubmed.ncbi.nlm.nih.gov/10132719
https://pubmed.ncbi.nlm.nih.gov/10132719
Autor:
R P, Perrillo, E R, Schiff, G L, Davis, H C, Bodenheimer, K, Lindsay, J, Payne, J L, Dienstag, C, O'Brien, C, Tamburro, I M, Jacobson, R, Sampliner, D, Feit, J, Lefkowitch, M, Kuhns, C, Meschievitz, B, Sanghvi, J, Albrecht, A, Gibas
Publikováno v:
The New England journal of medicine. 323(5)
Chronic hepatitis B is a common and often progressive liver disorder for which there is no accepted therapy. To assess the efficacy of treatment with interferon, we randomly assigned patients with chronic hepatitis B to one of the following regimens:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::163d5e42288c0711097b7c689727c931
https://pubmed.ncbi.nlm.nih.gov/2366843
https://pubmed.ncbi.nlm.nih.gov/2366843
Autor:
S, Ingber, I M, Jacobson
Publikováno v:
Gastroenterology clinics of North America. 19(2)
Cholelithiasis and its complications, along with malignancy, account for the majority of biliary and pancreatic diseases in the elderly and increase in frequency with advancing age. The presentation is often subtle and requires a high index of suspic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::252a4ed494bbe5a1bd8cdcb509dc46da
https://pubmed.ncbi.nlm.nih.gov/2194953
https://pubmed.ncbi.nlm.nih.gov/2194953
Autor:
G L, Davis, L A, Balart, E R, Schiff, K, Lindsay, H C, Bodenheimer, R P, Perrillo, W, Carey, I M, Jacobson, J, Payne, J L, Dienstag
Publikováno v:
Journal of hepatology. 11
To assess the efficacy of therapy with the antiviral agent interferon in chronic hepatitis C (non-A, non-B hepatitis), we randomly assigned 166 chronic hepatitis C patients to treatment with either 3 million or 1 million units of recombinant interfer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2236b2669ecf00a7d88b17f1e8455f8f
https://pubmed.ncbi.nlm.nih.gov/2127785
https://pubmed.ncbi.nlm.nih.gov/2127785
Autor:
I. M. Jacobson, L. S. Friedman
Publikováno v:
Current Opinion in Infectious Diseases. 2:272-286
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07f803d1a9177f9a54552f75b11de939
https://doi.org/10.1097/00001432-198904000-00019
https://doi.org/10.1097/00001432-198904000-00019